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Srf destabilizes cellular identity by suppressing cell-
type-speciﬁc gene expression programs
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Multicellular organisms consist of multiple cell types. The identity of these cells is primarily
maintained by cell-type-speciﬁc gene expression programs; however, mechanisms that
suppress these programs are poorly deﬁned. Here we show that serum response factor (Srf),
a transcription factor that is activated by various extracellular stimuli, can repress cell-type-
speciﬁc genes and promote cellular reprogramming to pluripotency. Manipulations that
decrease β-actin monomer quantity result in the nuclear accumulation of Mkl1 and the
activation of Srf, which downregulate cell-type-speciﬁc genes and alter the epigenetics of
regulatory regions and chromatin organization. Mice overexpressing Srf exhibit various
pathologies including an ulcerative colitis-like symptom and a metaplasia-like phenotype in
the pancreas. Our results demonstrate an unexpected function of Srf via a mechanism by
which extracellular stimuli actively destabilize cell identity and suggest Srf involvement in a
wide range of diseases.
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A ll cell types in an organism are generated through anumber of differentiation events that involve the loss ofone cell identity for another. The maintenance of cell
identity is crucial for organismal homeostasis and a loss of this
maintenance is associated with aging and diseases such as can-
cer1,2. How cell identity is regulated is thus a fundamental bio-
logical question.
Cell identiﬁcation is regulated by speciﬁc gene expression
programs. Extracellular signals such as growth factors, extra-
cellular matrices, and their stiffness are received by speciﬁc
receptors that transduce the signals intracellularly3, to regulate
the activity of transcription factors (TFs)4. TFs regulate gene
expressions for which regulatory elements including enhancers
and promoters are essential4. Master TFs regulate gene expres-
sions that are speciﬁc for cell identity by binding to many
enhancers, including super-enhancers, which encompass large
regions and have stronger activity5. Master TFs form a core
transcriptional network that primarily maintains the gene
expression program speciﬁc for the cell type6. Indeed, the ectopic
expression of master TFs can change the fate of somatic cells to
other cell types7. One of the most well-known examples of cell
fate change is the reprogramming of cells into induced plur-
ipotent stem cells (iPSCs), which have a potency equivalent to
embryonic stem cells (ESCs), by the overexpression of the master
TFs for ESCs (Oct4, Klf4, c-Myc, and Sox2 (OKMS)) in somatic
cells8. Yet, how master TFs maintain cell identity remains
unclear, presumably due to the fact that many crucial molecules
and pathways involved in the maintenance of cell identity are still
unknown. Reprogramming to iPSCs is one way to ﬁnd these
molecules and pathways.
Reprogramming needs to pass through several molecular
pathways and the genes involved in these pathways can be
identiﬁed by screenings9,10. Accordingly, many factors have been
reported as “roadblocks” of reprogramming and presumably
maintain somatic cell identity9,10. However, the majority of these
factors have been studied only in one speciﬁc cell type (typically
ﬁbroblasts), despite the fact that functional differences in road-
block factors depend on cell type11. To study cell-type-speciﬁc
mechanisms for cell identify maintenance, here we sought to
identify roadblock genes in two diverse cell types, neural and liver
cells. Knockdown screenings identify many cell-type-speciﬁc
genes in each cell type as well as ubiquitous genes including the
β-actin gene and genes involved in β-actin dynamics. The
manipulation of β-actin dynamics activates serum response factor
(Srf) through the canonical pathway12, which unexpectedly
downregulates cell-type-speciﬁc genes through direct binding, at
least partially. Misactivation of Srf in mice induces various
pathologies that have been associated with super-enhancers
responsible for maintaining cell identity. As Srf is activated by a
variety of extracellular signals13–16, our data indicate that Srf can
destabilize cell identity in response to exogenous cues in broad
cell types and suggest that Srf misactivation could be a novel
mechanism for the induction of various diseases.
Results
Cell-type-speciﬁc genes maintain cell identity. To identify the
factors involved in the maintenance of cellular identity, we used a
well-studied system that reprograms somatic cells into iPSCs8. To
identify inhibitory factors for cell reprogramming (i.e., factors
important for the maintenance of somatic cell identity), short
hairpin RNA (shRNA)-based knockdown library screenings were
performed using a reprogramming system of neural progenitor
cells (NPCs) as a model (Supplementary Fig. 1). The NPCs were
generated by in vitro differentiation of mouse ESCs and main-
tained in a two-dimensional culture condition17. Later, we
introduced into them a cocktail of the reprogramming factors
OKMS, inducible under the control of a doxycycline (Dox)-
inducible promoter. In addition, the NPCs carry a blasticidin-
resistant gene under the control of the endogenous Oct4 allele for
the selection of reprogrammed iPSCs. We also established a
“suboptimal” concentration of Dox (40 ng/ml) that failed to
induce cellular reprogramming, to create a meta-stable cellular
state that enhances sensitivity to a shRNA screening for the
identiﬁcation of factors associated with the maintenance of cel-
lular identity. Accordingly, at 40 ng/ml Dox, no colonies were
formed and no cells survived when selected for the Oct4-blas-
ticidin reporter. We then applied a genome-wide shRNA library
at this Dox concentration into the NPCs. No cells survived when
shLuc was introduced (negative control), but iPSC colonies
resistant to blasticidin emerged when the shRNA library was
introduced. To identify candidate shRNAs, we collected DNA
from these iPSCs, recovered shRNA sequences by PCR, and
analyzed the sequences by deep sequencing (Fig. 1a and Sup-
plementary Fig. 1). To further enrich shRNAs associated with the
promotion of reprogramming, we introduced a second library,
which was prepared using shRNA fragments ampliﬁed from
genomic DNA from the iPSCs in the ﬁrst screening, and repeated
the analysis. The enrichment of each shRNA sequence compared
with total sequence reads was calculated for the ﬁrst and second
screenings. As a result, 1544 and 60 shRNA sequences were
enriched ( > 1-fold), respectively (Supplementary Data 1). The
reliability of the screenings was conﬁrmed by experiments in
which shRNAs from the second screening were individually
checked for the promotion of reprogramming (Supplementary
Fig. 2a). We analyzed target genes using a database for expression
speciﬁcity across tissues18,19 and found that the shRNA targets
after the screenings were enriched with genes expressed in the
brain, which is consistent with the use of neuronal lineage cells as
the iPSC origin (Fig. 1b and Supplementary Figs. 2b and 3a). In
addition, genes more highly expressed in NPCs ( > 2-fold) com-
pared with those in ESCs (designated as “NPC genes”) were
enriched (Supplementary Fig. 3b). These results suggest that
knockdown of cell-type-speciﬁc genes accelerates reprogram-
ming, and that these genes tend to maintain the cell identity of
NPCs.
To clarify whether these results with NPCs, which are of
ectoderm origin, are also applicable to other lineages, we used
mouse hepatoblasts harboring a BAC transgene of Nanog-
EGFP11 (Fig. 1a and Supplementary Fig. 4a, b). These cells are
of endoderm origin and were isolated from fetal liver in primary
culture. Consistent with the NPC results, genes expressed in liver
were enriched in shRNA targets in efﬁciently reprogrammed cells
from hepatoblasts (Fig. 1b and Supplementary Data 2). In
addition, we found that a relatively small number of shRNA
targets in NPCs, hepatoblasts, and mouse embryonic ﬁbroblasts20
overlapped with one another (Fig. 1c, Supplementary Fig. 4c and
Supplementary Data 3). Although representative inhibitory genes
such as growth suppressor p5321 (also known as Tp53) and
epigenetic repressor Mbd322 were not found in shRNA targets in
NPCs or hepatoblasts, we found Cdk2ap1, which negatively
regulates proliferation23, and Dnmt3b, which confers repressive
epigenetic modiﬁcations24 (Supplementary Data 1 and 2),
suggesting that pathways with similar functions might inhibit
reprogramming but that the contribution of individual genes may
depend on the cell type25. Another representative pathway in
reprogramming is the mesenchymal-to-epithelial transition
(MET), in which mesenchymal and epithelial genes are down-
and upregulated, respectively26,27. NPCs express mesenchymal
genes11, whereas hepatoblasts express epithelial genes11. Accord-
ingly, the identiﬁed shRNA targets in NPCs, but not those in
hepatoblasts, could contain genes involved in the regulation of
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MET. An in silico analysis using the Ingenuity Pathway Analysis
(IPA) showed a signiﬁcant enrichment of genes related to
“Regulation of the Epithelial-Mesenchymal Transition Pathway”
in the ﬁrst screening of NPCs (P= 0.0036, Fisher’s exact test), but
no hits of MET/EMT-related terms in the screening of
hepatoblasts, suggesting that the importance of MET for
reprogramming may depend on cell type. Taken together, and
consistent with a previous report in which cell-type-speciﬁc
master TFs inhibited reprogramming11, our results suggest that
the repression of cell-type-speciﬁc genes promoted
reprogramming.
β-Actin repression promotes reprogramming. Although the
shRNA targets from the screenings contained many cell-type-
speciﬁc genes, we also found some genes that are ubiquitously
and highly expressed, such as the β-actin gene Actb (Supple-
mentary Data 1). Therefore, we investigated Actb function in
reprogramming. We ﬁrst conﬁrmed the effect of shRNAs for Actb
(shActb) on reprogramming by using two different shRNA
sequences to exclude the possibility of off-target effects. Both
shActb introduced by retrovirus vectors effectively repressed Actb
expression (Supplementary Fig. 5a). Introduction of these shActb
into NPCs enhanced the production of iPSCs by Dox addition, as
judged by Oct4 expression, alkaline phosphatase expression, and
2i resistance (Fig. 2a). Such an effect was attenuated by the co-
introduction of Actb (Fig. 2a). Together, these results indicate that
Actb repression promoted reprogramming. We also conﬁrmed
that iPSCs derived with shActb retrovirus were able to contribute
to various tissues such as neurons, cartilage, and digestive tissues
in chimeric mice, suggesting their pluripotency (Supplementary
Fig. 5b). In addition, although reprogramming can be enhanced
by the acceleration of cell proliferation28, Actb knockdown had
little effect on cell proliferation (Supplementary Fig. 5c), but it did
elevate the reprogramming rate (Supplementary Fig. 5d), sug-
gesting that Actb repression accelerates the dedifferentiation of
NPCs to promote reprogramming. We further address the con-
sequences of Actb repression later.
We also conﬁrmed the effect of Actb repression in hepatoblasts
and a ureteric bud cell (UBC) line, which is of mesoderm
origin29. As knockdown by shActb was weak in hepatoblasts
(Supplementary Fig. 6a), we also applied the CRISPR/Cas9 system
to repress Actb expression in hepatoblasts (Supplementary
Fig. 6b). The repression of Actb promoted reprogramming in
both cell types (Supplementary Fig. 6c, d), suggesting that β-actin
inhibits reprogramming during iPSC induction from cell types
across different germ layers.
Srf promotes reprogramming downstream of β-actin. To
identify the downstream targets of β-actin for transcriptional
regulation, we analyzed the global gene expression of NPCs with
shActb (Fig. 2b). In Gene Ontology (GO) analysis, downregulated
genes included those for neural functions and development
(Table 1). On the other hand, upregulated genes included those
for cytoskeleton and cell motility (Table 1), and the upstream
regions of these genes tended to contain consensus binding motifs
of Srf (Fig. 2c). Indeed, known Srf targets such as Acta2, Tagln,
Myl9, and Cnn1 were upregulated by Actb repression (Fig. 2b, d),
suggesting that β-actin depletion resulted in Srf activation (see
below), as previously reported for actin polymerization12. Con-
sistently, Srf overexpression also promoted reprogramming
(Fig. 3a) without accelerating cell proliferation (Supplementary
Fig. 7a), whereas knockdown of Srf suppressed reprogramming
(Fig. 3a and Supplementary Fig. 7b). Reprogramming was also
suppressed by the introduction of SrfΔN, which lacked the
N-terminal region that contained the MADS box for DNA and
cofactor binding30 (Fig. 3a and Supplementary Fig. 7c). On the
other hand, another truncation mutant, SrfΔC, which lacked
the C terminus but contained the MADS box, promoted
reprogramming (Fig. 3a and Supplementary Fig. 7c). These
results indicate that Srf promotes reprogramming through the
MADS-box-containing N-terminal region, presumably due to its
DNA- and/or cofactor-binding function. To address whether the
function of Srf in NPCs are conserved in other cell lineages,
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Fig. 1 Cell-type-speciﬁc genes inhibit reprogramming. a Outline of the screening strategy used to identify factors that inhibit reprogramming. b Cell-type-
speciﬁc genes are enriched by the screenings. Genes enriched in the second screening of NPCs and the high positive fraction in the screening of
hepatoblasts were subjected to tissue expression analysis with DAVID18, 19. Fisher’s exact test. c Factors that inhibit reprogramming are different among
cell types. Identiﬁed genes from the second screening of NPCs, the high positive fraction in the screening of hepatoblasts and Yang et al.20 were used to
generate the Venn diagram. Numbers indicate the number of genes
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promoted reprogramming in these cell types too (Supplementary
Fig. 7d, e), suggesting that the effect of Srf on reprogramming is
common in a broad range of cell types.
Depletion of β-actin activates Mkl1-Srf pathway. We next
addressed how β-actin regulated Srf activity. The polymerization
dynamics of β-actin is known to regulate Srf activity through a
pathway mediated by the nuclear-cytoplasmic shuttling of
megakaryoblastic leukemia 1 (Mkl1, also known as MRTF-A or
Mal), a cofactor of Srf12. The nuclear localization of Mkl1 is
controlled by binding with G-actin (β-actin monomer); Mkl1
is exported to the cytoplasm when it binds to G-actin, but it is
localized in the nucleus and can activate Srf when released from
G-actin12. Hence, the nuclear localization of Mkl1 indicates a low
abundance of G-actin within a cell. Immunocytochemistry of
Mkl1 revealed that although Mkl1 was predominantly localized in
the cytoplasm of control cells, it was more abundant in the
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Upregulated by Actb KD
a b
c d
Fig. 2 β-Actin inhibits reprogramming and Srf activity. a Knockdown of Actb gene expression enhances reprogramming. Reprogramming efﬁciencies from
NPCs are shown as iPSC colony numbers relative to shLuc+mock-introduced cells. Means ± SD are shown (n= 3). Dots indicate individual data points.
Student’s t-test (*P < 0.05). b Knockdown of Actb alters various gene expressions. A scatter plot comparing gene expressions of Actb-knockdown NPCs
and control cells. Blue dots and magenta dots show genes upregulated and downregulated > 2-fold, respectively. Some known Srf target gene symbols are
indicated. c Srf-binding consensus motifs are enriched upstream of genes upregulated by Actb knockdown. Genes upregulated > 2-fold in NPCs were
subjected to a motif search using Transfac to search protein-binding consensus sequences that were enriched in upstream regions. d Srf is activated by
Actb knockdown. Expression levels relative to control cells for each Srf target gene in NPCs are shown (n= 2, technical duplicate). Values are means ± SD
of the microarray data. Dots indicate individual data points
Table 1 Representative GO terms for genes downregulated
and upregulated by Actb knockdown
GO term P-value
Downregulated
Multicellular organismal process 9.06E–6
Animal organ development 4.10E–3
Regulation of release of sequestered calcium ion into cytosol 1.12E–2








ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03748-1
4 NATURE COMMUNICATIONS |  (2018) 9:1387 | DOI: 10.1038/s41467-018-03748-1 | www.nature.com/naturecommunications
Fig. 8a, b), as seen in the case of actin polymerization12. In
addition, transient treatment with jasplakinolide, a β-actin-
polymerizing compound, which increases the nuclear localiza-
tion of Mkl1 and activation of Srf12, promoted the early phase of
reprogramming (Supplementary Fig. 8c). In contrast, treatment
with latrunculin A, a β-actin-depolymerizing compound, sup-
pressed reprogramming (Supplementary Fig. 8c). Moreover,Mkl1
overexpression promoted reprogramming (Fig. 3c), whereas Mkl1
and Srf knockdown nulliﬁed the enhanced reprogramming efﬁ-
ciency caused by β-actin depletion (Supplementary Fig. 8d). In
contrast, the overexpression of Elk3 or Elk4, ternary complex
factors (TCFs) of another known Srf-activating pathway,
repressed reprogramming (Supplementary Fig. 8e). As TCFs
compete with Mkl1 for Srf binding31, this result suggests that
TCFs might decrease the binding of Mkl1 to Srf, thus weakening
the promotion of reprogramming. These results collectively
suggest that Srf promotes reprogramming by signaling the
G-actin pool depletion to downstream genes through Mk11.
Srf preferentially downregulates cell-type-speciﬁc genes. Next,
we explored the function of Srf in reprogramming. Reprogram-
ming from somatic cells to iPSCs involves an early (initiation)
phase, intermediate phase, and late (maturation and stabilization)
phase, and different factors and pathways are involved in each
phase9,27. To determine in which phase Srf promotes
reprogramming, we overexpressed Srf by lentiviral transduction
in NPCs at different time points. Interestingly, reprogramming
was enhanced only when Srf was overexpressed in the early phase
(Fig. 3d), a stage that is involved with the loss of somatic cell
identity before Oct4 is upregulated9,11. A similar result was
observed in hepatoblasts (Supplementary Fig. 9a) and UBCs
(Supplementary Fig. 9b), suggesting the conservation of Srf
function beyond germ layers.
To investigate this function in more detail, we analyzed global
gene expressions in Srf-overexpressing NPCs. Noting that Srf
targets mediated by Mkl1 were upregulated by Srf overexpression
(Fig. 4a and Supplementary Fig. 10a, b) and changes in gene
expressions caused by Srf overexpression resemble those caused
by Actb knockdown and Mkl1 overexpression (Supplementary
Fig. 10c), overexpression of Srf roughly mimicked the activation
of Srf. As the localization of Mkl1 was not altered by Srf
overexpression (Supplementary Fig. 10d), we concluded that the
upregulation of Mkl1-Srf target genes was due to the increased
proportion of Mkl1 that interacted with Srf in the nucleus and not
an increased nuclear import of Mkl1. We classiﬁed genes into
three groups: “NPC genes,” which are more highly expressed in
NPCs ( > 2-fold) than in ESCs; “ESC genes,” which are more
highly expressed in ESCs ( > 2-fold) than in NPCs; and
“ubiquitous genes,” which are speciﬁc neither for NPCs nor
ESCs. The percentages of “NPC genes,” “ESC genes,” and











































































































Bright field Mkl1 DAPI



































Fig. 3 Srf and its cofactor, Mkl1, promote reprogramming. a Srf promotes reprogramming. Values are means ± SD of the numbers of iPSC colonies produced
relative to control cells (n= 3). OE indicates overexpression. Dots indicate individual data points. Student’s t-test (***P < 0.0005, **P < 0.005, *P < 0.05).
b Mkl1 mainly localizes in the nucleus upon β-actin depletion. Immunoﬂuorescence microscopy of NPCs using anti-Mkl1 antibody and images of the
corresponding bright ﬁeld and DAPI staining. Bar, 20 µm. c Mkl1 promotes reprogramming. Values are means ± SD of numbers of iPSC colonies generated
from NPCs relative to the control (n= 3). Dots indicate individual data points. Student’s t-test (***P < 0.0005). d Srf promotes reprogramming at early
phase. NPCs were infected with egfp-expressing lentivirus or Srf-overexpressing lentivirus at the days indicated (d1 is the day of reprogramming initiation
by Dox addition). Vertical axis shows the reprogramming efﬁciency of Srf-overexpressing cells to egfp-expressing cells in logarithmic (log) scale (n= 3).
Dots indicate individual data points. Asterisks indicate statistically signiﬁcant differences between Srf overexpression and control on the day of virus
infection (Student’s t-test; *P < 0.05)
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and 43.8%, respectively. Microarray analyses showed that almost
half (47.0%) of the genes downregulated by Srf overexpression
were NPC genes, indicating a signiﬁcant number of cell-type-
speciﬁc genes are suppressed by Srf when compared with genes
that were not downregulated (P= 1.69 × 10–299, Fisher’s exact
test) (Fig. 4a, b). On the other hand, only 14.6% of genes
upregulated by Srf overexpression were NPC genes (Fig. 4a, b).
The NPC genes downregulated by Srf overexpression tended to
also be downregulated by shActb or Mkl1 overexpression
(Supplementary Fig. 10c), supporting the notion that β-actin
acted through Mkl1 and Srf. These results are consistent with
previous reports that showed Srf acts as a repressor as well as an
activator32. GO terms of the genes downregulated by Srf
overexpression included neuron-related terms with high
signiﬁcance (Table 2), whereas GO terms of genes upregulated
by Srf overexpression included known functions of Srf such as
mesoderm formation, cell adhesion, and motility33 (Table 2). We
also analyzed the repression of cell-type-speciﬁc genes by Srf in
hepatoblasts. As in NPCs, genes more highly expressed in
hepatoblasts ( > 3-fold) than in ESCs were designated as
“hepatoblast genes.” The proportion of hepatoblast genes in the
downregulated genes by Srf overexpression ( > 1.5-fold) was
32.9%, indicating an enrichment of hepatoblast genes when
compared with genes that were not downregulated (P= 8.31 ×
10–94, Fisher’s exact test) (Supplementary Fig. 10e). These data
suggest that Srf preferentially downregulates the expression of
cell-type-speciﬁc genes and that Srf activation, either by G-actin
reduction or Srf overexpression, promotes the loss of original cell
identity.
Srf removes active enhancer/promoter marks. To analyze the
mechanism by which Srf repressed cell-type-speciﬁc genes,
chromatin immunoprecipitation sequencing (ChIP-seq) using Srf
antibody was performed to map genome-wide Srf-binding sites in
NPCs. We also performed ChIP-seq for the active enhancer/
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Fig. 4 Srf preferentially downregulates cell-type-speciﬁc genes. a A scatter plot showing gene expressions that are > 2-fold different between Srf-
overexpressing NPCs and control cells. Blue dots show NPC genes, which are deﬁned as genes whose expression levels in NPCs are > 2-fold compared
with those in ESCs. b Cell-type-speciﬁc genes are enriched in genes downregulated by Srf overexpression. Asterisks indicate a signiﬁcant difference
between genes in the indicated group and all other genes (two-sided Fisher’s exact test; ***P < 0.0005). c Srf preferentially binds to open and H3K27ac-
marked genomic regions. The peak number in the overlapped area is based on the number of Srf-binding peaks. Overlaps were analyzed by the
hypergeometric test. d Srf removes adjacent H3K27ac in NPCs. Means of ChIP-seq signals around genomic regions to which Srf was bound within 2000 bp
from TSS (left panels) and other regions (right panel). e Matrices of consensus binding motifs of HDACs and Ep300 are enriched near Srf-binding sites.
Motif analyses of ChIP-seq data of Srf in NPCs indicated that matrices of the motifs of HDAC1, HDAC2, and Ep300 were enriched within 25 bp of the Srf-
binding sites in NPCs. Fisher’s exact test
Table 2 Representative GO terms for genes downregulated
or upregulated by Srf overexpression
GO term P-value
Downregulated
Olfactory receptor activity 2.16E–23
Sensory perception of chemical stimulus 7.97E–23
Neurological system process 8.29E–22
G-protein coupled receptor protein signaling pathway 1.20E–20
Upregulated
Blood vessel morphogenesis 2.84E–6
Pattern speciﬁcation process 8.11E–6
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chromatin regions in NPCs. These analyses revealed that
Srf-binding sites signiﬁcantly overlapped with open chromatin
regions and active enhancer/promoter regions (Fig. 4c). Indeed,
the intensity of the ChIP-seq signals of H3K27ac correlated with
those of Srf (Fig. 4d). We found that Srf overexpression decreased
H3K27ac levels around Srf-binding sites in the putative promoter
region (within 2000 bp from the transcription start site (TSS)) of
downregulated genes and other regions (Fig. 4d). We further
found that overexpression of Mkl1, which could activate Srf
(Supplementary Fig. 10c), preferentially downregulated cell-type-
speciﬁc genes (Supplementary Fig. 10f) similar to Srf over-
expression (Fig. 4b). H3K27ac levels around the Srf-binding sites
were also decreased by the overexpression of Mkl1 near the TSS
of downregulated cell-type-speciﬁc genes (Supplementary
Fig. 11a). Furthermore, the whole amount of H3K27ac was
comparable between Srf-overexpressing cells and control cells as
estimated by western blotting analysis (Supplementary Fig. 11b,
c), suggesting that Srf activity can inactivate adjacent genomic
regions. As the removal of H3K27ac was not found around Srf
near the TSS of upregulated genes (Fig. 4d), controlling H3K27ac
levels at promoters as well as remote sites31,32 could be a
mechanism by which Srf downregulates target genes. We found
an enrichment of motifs for histone deacetylases (HDACs), which
are involved in the inactivation of gene expression, near the Srf-
binding sites in addition to an enrichment of binding motifs for
Ep300 (also known as p300), which is required for enhancer
activation (Fig. 4e). Similarly, in hepatoblasts, Srf-binding regions
signiﬁcantly overlapped with H3K27ac (Supplementary Fig. 11d)
and the motifs of HDACs were enriched near the Srf-binding
sites (Supplementary Fig. 11e). This observation is consistent with
previous reports that demonstrated associations of HDACs with
Srf34,35. Overall, these results suggest that Srf removes histone
acetylation marks from active enhancers/promoters, possibly
through its cooperation with HDACs.
Srf activation leads to changes of subnuclear organization. The
subnuclear organization of the genome is closely associated with
gene expression and differentiation states36. We thus addressed
the effects of the β-actin-Srf pathway on the nuclear genome
organization by performing Hi-C analyses using β-actin-depleted
or Srf-overexpressing NPCs. By principal component analysis
(PCA) of the Hi-C data, one can map distinct subnuclear com-
partments, A and B, on the genome, between interactions that are
much less frequent than those within each compartment37.
Compartment A corresponds to the accessible, active, and early-
replicating euchromatin located in the interior of the nucleus,
whereas compartment B corresponds to the inaccessible, inactive,
and late-replicating heterochromatin located close to the nuclear
envelope37. In general, the distribution of compartments A and B
along the genome is considered cell-type speciﬁc38. PCA of the
Hi-C data revealed that A-to-B switching regions by both β-actin
depletion and Srf overexpression (without OKMS induction)
overlapped well with those regions observed after reprogramming
to iPSCs39 (Fig. 5a, b). Moreover, cell-type-speciﬁc genes were
enriched in A-to-B switching regions, but not in B-to-A switching
regions (Fig. 5c). However, statistical analyses showed no sig-
niﬁcance between Srf-binding sites and compartment changes
(hypergeometric test). The insigniﬁcance suggests that Srf indir-
ectly changes the 3D genome structure and/or a small sub-
population of Srf-binding sites are critical for the changes. Our
data nevertheless suggest that Srf destabilizes cell-type speciﬁcity,
partly through changes in the organization of subnuclear chro-
matin compartments, to promote the downregulation of cell-
type-speciﬁc genes. Clarifying exactly how the compartments are
changed by the β-actin-Srf pathway is an interesting future
question. In contrast to cell-type-speciﬁc genes, ESC genes were
not enriched in B-to-A switching regions by both β-actin deple-
tion and Srf overexpression (Supplementary Fig. 12a). These
genes were overlapped with the regions observed after repro-
gramming to iPSCs39 (Supplementary Fig. 12b, c), suggesting that
the reprogramming promoted by the β-actin-Srf pathway may
involve the priming of chromatin domains that contain non-ESC
genes for activation in addition to the domain-level suppression
of NPC genes.
Extracellular stimuli control cell-type genes through Srf. We
next investigated the activity of Srf to repress cell-type-speciﬁc
genes in response to extracellular mechanical stimuli. Srf is
activated when cells are on a stiffer matrix through changed actin
dynamics13,40. We thus examined whether the stiffness of
the extracellular matrix contributes to the maintenance of the






































A to B overlap (P< 0.05)
a b c
Fig. 5 β-Actin-Srf pathway induces a global reorganization of the subnuclear compartment. a Activation of the β-actin-Srf pathway alone induces a global
reorganization of the subnuclear compartment that resembles partial reprogramming. Venn diagram of the chromatin-organization changes from
compartment A to compartment B in NPCs. Peak numbers are shown. b A region on chromosome 13 where the patterns from A to B are similar in Actb
knockout, Srf overexpression in NPCs, and reprogramming to iPSCs. c Cell-type-speciﬁc genes are enriched in genes that change their subnuclear
compartment from A to B by the β-actin-Srf pathway. Asterisks and N.S. indicate a signiﬁcant difference and no signiﬁcant difference, respectively, between
genes in the indicated group and all other genes (two-sided Fisher’s exact test; *P < 0.05)
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03748-1 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:1387 | DOI: 10.1038/s41467-018-03748-1 |www.nature.com/naturecommunications 7
cultures on a matrix of 0.5 kPa, which is a stiffness close to that of
brain (soft; i.e., the physiological microenvironment of NPCs),
and 12 kPa (hard). The activity of Srf exhibited a positive
correlation with the stiffness, as judged by the expression of
Mkl1-mediated Srf targets such as Acta2 (Fig. 6a), consistent
with a previous report40. In contrast, genes that qualiﬁed as
cell-type-speciﬁc genes on the 0.5 kPa matrix were
signiﬁcantly downregulated in cells on the 12 kPa matrix
(Fig. 6b). As each cell type resides in the speciﬁc stiffness
of the surrounding microenvironment in vivo13,40, these results
suggest that Srf is able to downregulate cell-type-speciﬁc
gene expressions in response to deviations from optimal
stiffness and that extracellular stimuli can suppress cell identity
by activating Srf.
Srf is a risk factor for various diseases. To address the impor-
tance of Srf activity on the maintenance of cell identity and
homeostasis of an organism, we generated mice in which Srf
could be overexpressed by the administration of Dox. We
introduced Dox-regulated Srf followed by ires-mCherry in the
Col1a1 locus of an ESC line (carrying M2-rtTA in Rosa26) and
injected the established cells into blastocysts to produce chimeric
mice (KH2-Srf mouse; Fig. 6c and Supplementary Fig. 13a)41.
These chimeric mice expressed the transgene in various tissues
such as the epithelia of digestive tissues in response to Dox
(Supplementary Fig. 13b). In the intestine, these chimeric mice
reproducibly showed a colitis that resembled ulcerative colitis, a
bowel disease that is caused by a poorly understood mechanism,































































































Fig. 6 Srf misactivation causes various diseases. a Srf activity is regulated by an exogenous cue, extracellular matrix stiffness. The expressions of Srf target
genes in NPCs cultured on matrices of various stiffness relative to the value of each gene on the softest matrix (0.5 kPa). Values are means ± SD of the
relative expression levels normalized to Gapdh expression (n= 3). Dots indicate individual data points. b Cell-type-speciﬁc genes are downregulated by Srf
with stiffness. Percentages of genes differentially regulated in NPCs among cell-type-speciﬁc genes and other genes between 0.5 and 12 kPa matrices.
Two-sided Fisher’s exact test (***P < 0.0005, **P < 0.005, *P < 0.05). c Structure of transgenes in KH2-Srf mice. d Srf misactivation causes diseases.
Immunohistological observations of chimeric mice that were treated with Dox for 7 days. Upper images are representative images of hematoxylin/eosin
staining (HE) and lower images are roughly corresponding view ﬁelds of immunohistochemistry sections for Srf ectopic expression (mCherry) in colon and
pancreas in a chimeric mouse overexpressing Srf. Right panels of each tissue are magniﬁed views of the areas indicated by the squares in the respective left
panels. Arrows indicate sites exhibiting crypt abscess. Bars, 200 µm
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inﬁltration, which caused dropouts of epithelia and crypt abscess
in the colon (Fig. 6d and Table 3). The lesioned parts coincided
well with the area where ectopic Srf was expressed (Fig. 6d). Hnisz
et al.42 have reported that single-nucleotide polymorphisms
(SNPs) in super-enhancers are associated with various diseases
including ulcerative colitis in humans42. As these enhancers
control cell-type-speciﬁc gene expressions, they suggested that the
destabilization of cell identity can cause diseases42. Our results are
consistent with that report and suggest that Srf misactivation is
potentially involved in the pathology of ulcerative colitis by
repressing cell-type-speciﬁc genes in colon tissues. Abnormalities
were also reproducibly found in other tissues that expressed
ectopic Srf, such as acinar-to-ductal metaplasia (ADM)-like
alterations in the pancreas (Fig. 6d and Table 3) and dysplasia-
like observations in the stomach (Supplementary Fig. 13c and
Table 3), both of which are symptoms associated with
tumorigenesis.
To verify the possible involvement of SRF in diseases, we re-
analyzed publically available human microarray data of diseases
associated with SNPs in super-enhancers (see Hnisz et al.42)
including ulcerative colitis. We performed TRANSFAC motif
analyses for TF-binding sites in genes downregulated in patient
tissues. In ulcerative colitis, to exclude secondary effects of
inﬂammation, data from patients before the onset of inﬂamma-
tion were used43. Based on our analyses, we found that SRF-
binding motifs were enriched in cells from various disease types,
such as sigmoid colon for ulcerative colitis, T-helper cells for type
1 diabetes, hippocampus for Alzheimer’s disease, T-helper cells
for multiple sclerosis, and atrial cardium for atrial ﬁbrillation
(Supplementary Fig. 14a). Moreover, cell-type-speciﬁc genes were
enriched in the downregulated genes of these diseases (Supple-
mentary Fig. 14b), consistent with Hnisz et al.42.





Phenotype Dox+ Dox – P-value
Stomach 7 Dysplasia-like 5/5 0/4 0.008
Pancreas 3 ADM-like 3/3 0/4 0.029
Colon 3 UC-like 3/3 0/4 0.029
Dox+ and Dox – indicate Srf-overexpressing and control mice, respectively. Two-sided Fisher’s

























Fig. 7 A schematic model indicating that Srf destabilizes cell identity by repressing cell-type-speciﬁc genes. a A model of Srf-related pathways to repress
cell-type-speciﬁc gene expressions. Srf preferentially binds to open regions which preferentially contain cell-type-speciﬁc genes. Various signals, such as
Actb expression changes and β-actin polymerization dynamics, are transduced to Srf. Srf activated by Mkl1 inactivates the surrounding regions, possibly by
recruiting or activating HDACs. Other signals that regulate Srf through β-actin-independent pathways could also participate in this regulation. b A
schematic view of a possible mechanism by which misactivation of Srf causes diseases. When the activity of Srf is at physiological levels, cell-type-speciﬁc
genes are normally expressed. On the other hand, when Srf is activated at non-physiological levels (misactivation), these genes are repressed, triggering
malfunction of the cells and tissues and sometimes leading to disease
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As these diseases are known to be associated with SNPs in
super-enhancers42, we next examined possible associations
between Srf and super-enhancers. We used the ROSE algo-
rithm5,42,44 and predicted 967 super-enhancer regions in mouse
NPCs. These super-enhancers were signiﬁcantly overlapped with
Srf-binding sites that had been determined by ChIP-seq
(Supplementary Fig. 15). Collectively, these data suggest that Srf
represses cell-type-speciﬁc genes in part through cell-type-speciﬁc
enhancers and/or promoters, and that appropriate Srf activity is
necessary to maintain cell identity and the healthy state of an
organism (Fig. 7a, b).
Discussion
Here we demonstrate that extracellular stimuli activate Srf to
suppress cell identity. We showed that the reprogramming of cells
from multiple germ layers is inhibited by cell-type-speciﬁc genes,
which is in agreement with a previous report11. We further found
that a ubiquitously-expressed gene, Actb, which encodes β-actin,
also inhibited reprogramming by regulating downstream cell-
type-speciﬁc genes. In addition, the repression of Actb or reduc-
tion of G-actin increased the nuclear localization of Mkl1, a
cofactor of Srf, to canonically activate Srf12. Intriguingly, we
found that Srf overexpression alone signiﬁcantly downregulated
cell-type-speciﬁc genes downstream of Mkl1. Mechanistically, Srf
bound to active enhancers/promoters to diminish the active mark
around its binding sites and disrupt cell-type-speciﬁc patterns of
the chromatin organization. Enhancers that regulate cell-type-
speciﬁc genes should be vulnerable to perturbation of their
components as exempliﬁed by its binding sites and Brd45,42,44.
Thus, interference of Srf with any components of these enhancers
could downregulate cell-type-speciﬁc genes even without chan-
ging active enhancer/promoter marks or chromatin organization.
In addition, we show that the misactivation of Srf in mice caused
various pathologies and found indications that Srf might con-
tribute to the repression of cell-type-speciﬁc genes in human
disease samples. These results suggest that Srf is able to suppress
cell identity in a variety of cell types and that Srf activation by
various stimulations in vivo can trigger various diseases.
A variety of extracellular stimuli are known to regulate Srf
activity. For example, soluble factors bound to speciﬁc receptors
(e.g., receptor tyrosine kinases and G-protein-coupled receptors)
transduce signaling to Srf through the Rho-β-actin pathway45. In
addition, although the expression of Actb is thought to be ubi-
quitous, the expression level changes in response to extracellular
stimuli46, suggesting such extracellular stimuli can regulate G-
actin quantity and hence Srf activity. Moreover, mechanical cues
such as stiffness of the extracellular matrix and cell shape regulate
Srf activity13,40. In this study, we show that Srf activation results
in the downregulation of cell-type-speciﬁc gene expressions to
promote the loss of cell identity. Taking into consideration that
each cell type depends on its microenvironment, or niche3, this
study provides a mechanism that actively destabilizes cell identity
in response to changes in niche signaling (i.e., changes in soluble
factors and the extracellular matrix).
Why Srf has a “dedifferentiation” function is an open question.
Srf is necessary for the differentiation of various cell types,
including mesoderm47 and epidermal cells13. The target genes of
Srf depend on the cell type48 and belong to a variety of functional
categories, including genes encoding AP-1 family TFs49, cytos-
keletal proteins33, and developmental processes47. Consistently,
our data showed that Srf targets cell-type-speciﬁc genes in a way
that corresponds with the cell type. As promoters and enhancers
of cell-type-speciﬁc genes are likely in open (active) states, Srf
might preferentially (opportunistically) bind to the open and
active regions of these genes (Fig. 4c), as reported for other TFs50.
Srf function involves the recruitment of Mkl proteins. As Mkls
are relatively large molecules of around 100 kDa, their recruit-
ment could cause steric inhibition on molecules assembled in
promoters and enhancers. Alternatively, Srf may recruit repres-
sive molecules such as HDACs. The repression of active enhan-
cers for cell-type-speciﬁc genes promotes differentiation51. Thus,
the physiological role of Srf may be to repress genes speciﬁc for
undifferentiated cells in response to cues from the micro-
environment and promote differentiation. Interestingly, MADS
box family TFs, to which Srf belongs, are evolutionarily conserved
among eukaryotes, from unicellular to higher metazoans, and a
MADS box TF is able to promote the formation of embryonic
callus (i.e., dedifferentiation) in plants52. Our data showed that
MADS box in Srf was necessary to promote reprogramming
(Fig. 3a and Supplementary Fig. 7c), suggesting that the ability of
MADS box TFs to promote dedifferentiation by gene repression
in response to environmental cues may be general in a wide range
of eukaryotes. Further studies will be needed to clarify this
mechanism.
Ulcerative colitis is a chronic autoimmune disease that some-
times causes cancer, but its original cause and pathology have
remained largely unknown. This is partly due to a lack of animal
models that accurately reproduce the disease. We show here that
Dox-controlled Srf-overexpressing mice may be a useful model
for ulcerative colitis (Fig. 6d and Table 3). It is possible that
microenvironmental stimuli in the colon could misactivate SRF to
cause a loss of cell functions, which may facilitate autoimmune
responses through cell lysis53. Moreover, we also showed possible
involvement of SRF misactivation in other diseases (Supple-
mentary Fig. 14). A similar observation of SRF misactivation in
type 2 diabetes has been reported, and SRF inhibition by a che-
mical compound restored the cell function (glucose uptake)
in vitro and in vivo54. In addition, SRF activation is also suggested
to be involved in the progression of ﬁbrosis. Fibrosis is found in
many diseases and increases matrix stiffness55. Therefore, SRF
activation may exacerbate symptoms by accelerating the loss of
cell functions in the affected areas. Taken together, we suggest
that Srf may be a novel causative factor for a wide range of
diseases, and that the Srf pathway can be an alternative target for
the development of therapeutic agents.
In conclusion, we have shown that cell identity can be actively
destabilized by Srf activation in response to extracellular stimuli.
Multiple signals that decrease the amount of G-actin are able to
activate Srf, and thus can regulate the maintenance of cell iden-
tity. Finally, proper Srf activity may be essential for the preven-
tion of various diseases. Investigating the destabilization of cell
identity in many contexts, including reprogramming, regenera-
tion and various diseases, should reveal essential mechanisms for
cell identity maintenance and advance the development of new
technologies for cell reprogramming and related applications.
Methods
Plasmid constructions. A piggyBac transposon vector, PB-TA-ERN-OKMS, car-
rying Dox-dependent promoter-driven OKMS genes linked in tandem were con-
structed as follows. Using Gateway cloning with LR Clonase II (Thermo Fisher
Scientiﬁc), the pENTR-OKMS entry vector56 was introduced into a piggyBac
vector, PB-TA-ERN (containing a neomycin-resistant gene), which contained a
constitutive rtTA expression unit and Dox-dependent expression unit57. For
in vitro overexpression experiments using retrovirus vectors, pMXs-MCS6l-IP was
constructed by replacing the neomycin-resistant gene in pMXs-MCS6l-IN11 to a
puromycin-resistant gene. Kozak consensus sequence (CCACC) followed by open
reading frames (ORFs) encoding enhanced green ﬂuorescent protein (EGFP), β-
actin, Mkl1, Elk1, Elk3, Elk4, Srf, and Srf lacking a 217 aa region from amino acid
position (from the ﬁrst N-terminal methionine) 2 to 218 (SrfΔN) and Srf lacking
C-terminal 239 aa (SrfΔC) were inserted into the cloning site using SﬁI. Actb, Elk1,
Elk3, and Elk4 were codon-optimized for expression in mouse cells. For in vitro
overexpression experiments using lentivirus vectors, pLenti6.3/V5-DEST (Thermo
Fisher Scientiﬁc) was used as the backbone (destination vector). An attL site fol-
lowed by Kozak consensus sequence, the ORFs of egfp and Srf, and another attL
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site were cloned into pUC57kan vector to produce entry vectors. The destination
vector and the entry vectors were subjected to LR reaction to produce pLenti6.3/
V5-DEST-EGFP and pLenti6.3/V5-DEST-Srf using LR Clonase II.
For the Actb and Srf knockdown experiments using retrovirus vectors, pSilencer
5.1-H1 Retro vector (Thermo Fisher Scientiﬁc) was used. The oligo sets
shActb#1_F (5′-GAT CCG TTA AAT CTT CCG CCT TAA TAC TTC ATT CTT
CCT GTC AGA AAT GAA GTA TTA AGG CGG AAG ATT TAA TTT TTA-3′)/
shActb#1_R (5′-AGC TTA AAA ATT AAA TCT TCC GCC TTA ATA CTT CAT
TTC TGA CAG GAA GAA TGA AGT ATT AAG GCG GAA GAT TTA ACG-3′)
and shActb#2_F (5′-GAT CCG TAA TAG TCA TTC CAA GTA TCC ATG AAA
TTC AAG AGA TTT CAT GGA TAC TTG GAA TGA CTA TTA TTT TTA-3′)/
shActb#2_R (5′-AGC TTA AAA ATA ATA GTC ATT CCA AGT ATC CAT GAA
ATC TCT TGA ATT TCA TGG ATA CTT GGA ATG ACT ATT ACG-3′) for
Actb; shSrf#1_F (5′-GAT CCG CGG GAC TGT GCT CAA GAG TTT CAA GAG
AAC TCT TGA GCA CAG TCC CGT TTT TA-3′)/shSrf#1_R (5′-AGC TTA AAA
ACG GGA CTG TGC TCA AGA GTT CTC TTG AAA CTC TTG AGC ACA
GTC CCG CG-3′) and shSrf#2_F (5′-GAT CCG CTG CAG CCC ATG ATC ACC
ATT CAA GAG ATG GTG ATC ATG GGC TGC AGT TTT TA-3′)/shSrf#2_R
(5′-AGC TTA AAA ACT GCA GCC CAT GAT CAC CAT CTC TTG AAT GGT
GAT CAT GGG CTG CAG CG-3′) for Srf; shMkl1#1_F (5′-GAT CCG TAA CAT
GTA GAC ACC TGC CAT TGC CTC TTC AAG AGA GAG GCA ATG GCA
GGT GTC TAC ATG TTA TTT TTA-3′)/shMkl1#1_R (5′-AGC TTA AAA ATA
ACA TGT AGA CAC CTG CCA TTG CCT CTC TCT TGA AGA GGC AAT
GGC AGG TGT CTA CAT GTT ACG-3′) and shMkl1#2_F (5′-GAT CCG CAG
GTA AAT TAC CCA AAG GTA TTC AAG AGA TAC CTT TGG GTA ATT TAC
CTG TTT TTA-3′)/shMkl1#2_R (5′-AGC TTA AAA ACA GGT AAA TTA CCC
AAA GGT ATC TCT TGA ATA CCT TTG GGT AAT TTA CCT GCG-3′) for
Mkl1; and shEGFP_F (5′-GAT CCG ACA ACA GCC ACA ACG TCT ATA TCA
TGG TCT CTT GAA CCA TGA TAT AGA CGT TGT GGC TGT TGT TTT TTA-
3′)/shEGFP_R (5′-AGC TTA AAA AAC AAC AGC CAC AAC GTC TAT ATC
ATG GTT CAA GAG ACC ATG ATA TAG ACG TTG TGG CTG TTG TCG-3′)
and shLuc_F (5′-GAT CCG ACA ACC GCG AAA AAG TTG CTT CAA GAG
AGC AAC TTT TTC GCG GTT GTT TTT TTG GAA A-3′)/shLuc_R (5′-AGC
TTT TCC AAA AAA ACA ACC GCG AAA AAG TTG CTC TCT TGA AGC
AAC TTT TTC GCG GTT GTC G-3′) for negative controls were annealed and
ligated into the EcoRI/HindIII-digested plasmid to construct vectors to be used for
virus production. For the knockout of Actb using a CRISPR/Cas9 lentivirus system,
pLentiCRISPR (Addgene plasmid 49535) vector was used. The oligo sets CRISPR-
Actb#1_F (5′-CAC CGG GAT GAC GAT ATC GCT GCG C-3′)/CRISPR-
Actb#1_R (5′-AAA CGC GCA GCG ATA TCG TCA TCC C-3′) and CRISPR-
Actb#2_F (5′-CAC CGT CGC GGG CGA CGA TGC TCC C-3′)/CRISPR-
Actb#2_R (5′-AAA CGG GAG CAT CGT CGC CCG CGA C-3′) were annealed
and ligated into the BsmBI-digested plasmid.
Cell culture. N31 and N31P cells are mouse NPC lines described previously by
us11. In brief, an ESC line EB5 carrying ires-BSDpA in Oct4 was differentiated
in vitro to establish an NPC line, NSEB5-2C11. Dox-dependent promoter-driven
OKMS genes as well as a CAG-driven rtTA transgene were conveyed by piggyBac
transposons and separately introduced into NSEB5-2C cells by co-transfection with
pCAG-PBase11. Cells were reprogrammed to iPSCs by the addition of Dox.
N31 cells were established by the differentiation of these iPSCs. N31P cells are N31
derivatives in which the Pax6 transgene is introduced by a Tol2 transposon system.
These cells are almost identical to N31 cells in gene expression, proliferation, and
morphology, but their reprogramming efﬁciency is lower11. Therefore, N31P is
better than N31 for detecting shRNAs that accelerated reprogramming. NPCs were
maintained on a gelatin-coated culture plate in a NPC medium consisting of RHB
basal (StemCells) containing epidermal growth factor (EGF) (Peprotech) at 10 ng/
ml and human basic ﬁbroblast growth factor (bFGF) (Peprotech) at 10 ng/ml. NPC
culture also used another NPC medium, N2B27 medium, which was purchased
(Takara) or prepared as a 1:1 mixture of Neurobasal (Thermo Fisher Scientiﬁc),
and Dulbecco’s modiﬁed Eagle’s medium (DMEM)/F12 (1:1) with L-glutamine and
sodium bicarbonate (Thermo Fisher Scientiﬁc) supplemented with 1 ×
N2 supplement (Thermo Fisher Scientiﬁc), 1 × B-27 supplement (Thermo Fisher
Scientiﬁc), an additional 500 µM L-glutamine (Thermo Fisher Scientiﬁc), 10 µg/ml
insulin (Wako), and 37.5 µg/ml bovine serum albumin (BSA) fraction V (Sigma-
Aldrich) supplemented with 10 ng/ml EGF and 10 ng/ml bFGF. NSEB5-2C or
N31 cells were used as NPCs for molecular biological analyses. To analyze the effect
of extracellular matrix stiffness on gene expression, N31 cells and N31 cells
expressing shSrf#1 (see above) were maintained in a NPC medium without EGF or
bFGF on matrices (0.5, 2, or 12 kPa stiffness) lied over culture dishes coated with
type I collagen (Matrigen).
Hepatoblasts HNG2 are clonally expanded primary cells from the fetal (E13.5)
liver of STOCK Tg (Nanog-GFP, Puro)1Yam mice, established by us11. HNG2
carries the BAC-transgenic locus of Nanog-GFP, which allows us to analyze
reprogramming efﬁciency. In HNG2, PB-TA-ERN-OKMS was introduced by
lipofection with pCAG-PBase using Lipofectamine 2000 (Thermo Fisher Scientiﬁc)
and 2 mg/ml G418 (Sigma-Aldrich) was added to establish HOKMSCN. These cells
were maintained on a type IV collagen-coated culture plate in a medium consisting
of a 1:1 mixture of DMEM/Ham’s F-12 with L-glutamine, HEPES, and sodium
pyruvate (Wako) supplemented with 10% fetal bovine serum (FBS) (vol/vol)
(Nichirei Bioscience), 1 µg/ml insulin (Wako), 100 nM dexamethasone (Sigma-
Aldrich), 10 mM nicotinamide (Sigma-Aldrich), 50 µM β-mercaptoethanol
(Nacalai Tesque), 50 ng/ml human recombinant hepatocyte growth factor (HGF;
Peprotech), and 20 ng/ml EGF.
Mouse UBCs (from Kenji Osafune)29 were maintained on a gelatin-coated
culture plate in DMEM (Wako) supplemented with 10% FBS (Thermo Fisher
Scientiﬁc) and 1 mM sodium pyruvate (Nacalai Tesque). In UBCs, PB-TA-ERN-
OKMS was introduced by lipofection with pCAG-PBase using Lipofectamine 2000
and 2 mg/ml G418 was added to establish UOKMSCN.
Mycoplasma contamination was checked for all the cell types using MycoAlert
Mycoplasma Detection Kit (Lonza).
Cell reprogramming. The culturing conditions for the reprogramming assays are
summarized in Supplementary Fig. 16. In brief, cells were cultured in maintenance
media with or without EGF, bFGF, or HGF for the ﬁrst several days, then in
GMEM (Wako) supplemented with 10% Knockout Serum Replacement (Thermo
Fisher Scientiﬁc), 1 μM adrenocorticotropic hormone, 1 mM sodium pyruvate
(Nacalai Tesque), 1 × nonessential amino acids (Nacalai Tesque), 100 μM β-mer-
captoethanol, and 1000 U/ml of leukemia inhibitory factor (LIF) (Millipore), and/
or N2B27 supplemented with 2i inhibitor and 1000 U/ml of LIF. The medium was
replaced with ESC medium (GMEM supplemented with 10% FBS (Thermo Fisher
Scientiﬁc), 1 mM sodium pyruvate, 1 × non-essential amino acids, 100 μM β-
mercaptoethanol, and 1000 U/ml of LIF (Millipore)). Dox was added at the con-
centrations indicated in the ﬁgures. Media were replaced with fresh media every 2
or 3 days. For N31, N31P, and UOKMSCN, cultured cells were stained for alkaline
phosphatase expression using ALP Staining Kit (Muto Pure Chemicals). For
HOKMSCN, cultured cells were analyzed for EGFP expression as an indicator of
Nanog expression using FACS BD Accuri (BD Biosciences). Statistical analyses
were performed by F-test and one-sided Student’s t-test to test enhancement and
repression of reprogramming efﬁciencies unless stated otherwise.
Genome-wide shRNA screening. To construct piggyBac vectors based on a
shRNA screening system, a pooled shRNA library that targets whole mouse
transcripts (GeneNet Mouse 40 K, SBI) was cloned into the BamHI-EcoRI site of
the PB-H1-ccdB-EF1a-RiH piggyBac vector. The sequence and complexity of the
cloned shRNA library was conﬁrmed by amplicon sequencing using MiSeq. Then,
the piggyBac shRNA library was introduced into two target cell lines, N31P cells
and HOKMSCN, by the electroporation of pCAG-PBase and library plasmids using
NEPA21 electroporator (Nepagene) and lipofection using Lipofectamine 2000,
respectively. Cells were selected with hygromycin and cultured as summarized in
Supplementary Figs. 1 and 4a, b. For NPCs, “suboptimal” concentrations of Dox
(40 ng/ml) were applied to induce basal levels of OKMS. In this condition, the
formation of iPSC colonies was not induced to facilitate the detection of hit
shRNAs. In the screening using hepatoblasts, 1000 ng/ml Dox was applied to
reprogram cells and ﬂuorescence-activated cell sorting (FACS) was used to separate
negative, low positive, middle positive, and high positive fractions for Nanog
expression. Genomic DNAs were isolated using PureLink Genomic DNA Mini Kit
(Thermo Fisher Scientiﬁc). To construct a library for the second round of shRNA
screening with NPCs, shRNA sequences were ampliﬁed from the genomic DNA
isolated from iPSC colonies in the ﬁrst screening using the following primers:
PB_shRNA_Fwd (5′-GGG TAG TTC TTT AGA CGA TGA GCA T-3′) and
PB_shRNA_Rev (5′-GCT TGT GGT CTC TTA TAG CCG CG-3′). Ampliﬁed
shRNA fragments were digested with BamHI/EcoRI and cloned into the PB-H1-
ccdB-EF1a-RiH vector. To amplify the shRNA sequences and to add the sample
index for deep sequencing, the following primer sets were used: Multiplex Rd1
fwd_PB (5′-ACA CTC TTT CCC TAC ACG ACG CTC TTC CGA TCT NNN
NTG TAT GAG ACC ACT TGG ATC CG-3′) (NNNN is a 4 bp sample index) and
Multiplex Rd2 rev_PB (5′-GTG ACT GGA GTT CAG ACG TGT GCT CTT CCG
ATC TNN NNG ATC GCC CGG GTT TGA ATT C-3′) (NNNN is an index).
Next, the second PCR was performed to add adapter sequences for the Illumina
sequencing reaction using the following primers: Multiplex P5 fwd (5′-AAT GAT
ACG GCG ACC ACC GAG ATC TAC ACT CTT TCC CTA CAC GAC GCT C-
3′) and Multiplex P7 rev (5′-CAA GCA GAA GAC GGC ATA CGA GAT GTG
ACT GGA GTT CAG ACG TGT GCT C-3′). After size extraction and puriﬁcation
by MonoFas DNA Puriﬁcation Kit I (GL Sciences), the quality and quantity of the
samples were analyzed by TapeStation 2200 (Agilent Technologies) and KAPA
Library Quantiﬁcation Kit for Illumina (Nippon Genetics). Amplicons were sub-
jected to deep sequencing using MiSeq (Illumina) for NPCs and HiSeq 2500
(Illumina) for hepatoblasts. Ratios of each shRNA sequence among total reads were
compared between samples before and after each screening (for NPCs) or between
each Nanog-positive and -negative fraction to calculate the enrichment of each
shRNA sequence.
The identiﬁed genes were subjected to DAVID functional annotation
analysis18,19 (http://david.abcc.ncifcrf.gov) and the Expression Analysis for
Canonical Pathways using the IPA (Tomy Digital Biology).
Fluorescence-activated cell sorting. Cells were suspended in FACS buffer (2%
BSA in phosphate-buffered saline (PBS) (Nacalai Tesque)) and analyzed and sorted
by FACS Aria II SORP (Becton, Dickinson and Company). Gating was conducted
using the ﬂuorescence intensity and positive rate of four populations: high, 18,182
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mean ﬂuorescence intensity (MFI); middle, 5985 MFI; low, 1695 MFI; and nega-
tive, 63 MFI. The positive and negative populations were separately collected using
the cell sorter and used for the deep sequencing of shRNA sequences in the cells.
Production of virus vectors. To prepare retrovirus vectors, Plat-E cells (Cell
Biolabs) were seeded in DMEM medium supplemented with 10% FBS and 1mM
sodium pyruvate the day before plasmid transduction. The plasmid DNAs of
pMXs- or pSilencer-based vectors were introduced into Plat-E cells using Fugene 6
transfection reagent (Promega) according to the manufacturer’s instructions. After
incubation for 1 day, media were replaced with maintaining media for each cell
type used. Cells were cultured for an additional 24 h and virus-containing super-
natants were collected and centrifuged to remove cell contaminants. Viruses were
infected with cells in medium containing 4 μg/ml polybrene (Nacalai Tesque)
overnight. After replacement with fresh media, infected cells were selected by
puromycin (5 µg/ml) for all analyses, except for examination of the reprogramming
efﬁciency.
To prepare lentivirus vectors, HEK293T cells (ATCC) were seeded in DMEM
supplemented with 10% FBS and 1 mM sodium pyruvate the day before plasmid
transduction. Cells were co-transfected with pLenti-based vectors, psPAX2, and
pCMV-VSV-G vector DNAs using Lipofectamine 2000. After incubation for 1 day,
the medium was replaced with NPC medium without EGF or bFGF for NPCs,
hepatoblast medium without EGF or HGF for hepatoblasts, or DMEM
supplemented with 10% FBS for kidney cells. Cells were cultured for an additional
24 h and virus-containing supernatants were collected and centrifuged to remove
cell contaminants. These virus solutions were dispensed into aliquots and kept at –
150 °C until use. Cells were infected with viruses overnight.
Reverse transcription-quantitative PCR. Total RNAs were isolated using RNeasy
Mini Kit (Qiagen) according to the manufacturer’s recommendations. First-strand
DNAs were synthesized by reverse transcription using SuperScript III reverse
transcriptase (Thermo Fisher Scientiﬁc). A mixture of oligo(dT)20 and random
hexamer was used as the primers (Thermo Fisher Scientiﬁc). Using these templates,
quantitative PCR (qPCR) was performed using GoTaq qPCR Master Mix (Pro-
mega) in StepOne Real-time PCR System (Thermo Fisher Scientiﬁc). The primer
sets used were Gapdh_F (5′-GTG TTC CTA CCC CCA ATG TGT-3′) and
Gapdh_R (5′-ATT GTC ATA CCA GGA AAT GAG CTT-3′) for Gapdh; Actb_F
(5′-AGC TGT GCT ATG TTG CTC TAG ACT T-3′) and Actb_R (5′-CAT AGA
GGT CTT TAC GGA TGT CAA C-3′) for Actb; Srf_in3UTR_F (5′-TTC CCG
TCC GAG GAA ACA T-3′) and Srf_in3UTR_R (5′-GGC TCT TTT GAC CCA
GAC CAT-3′) for Srf; Acta2_F (5′-GTG CTA TGT AGC TCT GGA CTT TGA-3′)
and Acta2_R (5′-TAG CAT AGA GAT CCT TCC TGA TGT C-3′) for Acta2;
Myl9_F (5′-CTC AGG CTT CAT CCA CGA G-3′) and Myl9_R (5′-GTA GTT
GAA GTT GCC CTT CTT ATC A-3′) for Myl9; Tagln_F (5′-ACT AGT GGA
GTG GAT TGT AGT GCA G-3′) and Tagln_R (5′-TCC TTA CCT TCA TAG
AGG TCA ACA G-3′) for Tagln; and Cnn1_F (5′-AAG GTC AAT GAG TCA
ACT CAG AAC T-3′) and Cnn1_R (5′-AGG AGA GTG GAC TGA ACT TGT
GTA T-3′) for Cnn1.
Western blot analyses. For the western blotting analysis, protein samples were
prepared by lysing cells with RIPA buffer (20mM Tris-HCl, 100mM NaCl, 0.1%
(w/v) SDS, and 1% (v/v) Nonidet P-40 (NP-40) pH 8.0), except for the detection of
H3K27ac, in which case nucleic lysis buffer (10mM Tris-HCl, 10mM EDTA, 1%
SDS, and 200mM NaCl pH 7.5) was used. Cell contaminants were removed by
centrifugation. The samples and the size marker (Bio-Rad, 161-0376) were resolved
on 4–20% gradient SDS-polyacrylamide gel (Mini-PROTEAN TGX; Bio-Rad).
Proteins were transferred to a polyvinylidene diﬂuoride membrane (Trans-Blot
Turb Transfer Pack; Bio-Rad), which was subsequently blocked in Blocking One
(Nacalai Tesque) and incubated overnight at 4 °C with primary antibodies anti-β-
actin (produced in mouse; AC-74; Sigma-Aldrich, A5316), anti-Srf (produced in
rabbit using residues surrounding Ser375 of human SRF as an immunogen; D71A9;
Cell Signaling Technology, 5147), anti-Srf (produced in rabbit using a.a.65-95 of
human SRF as an immunogen; Sigma-Aldrich, SAB4502852), anti-H3K27ac (pro-
duced in rabbit; D5E; Cell Signaling Technology, 8173), and anti-Gapdh (produced
in mouse; 6C5; Millipore, CB1001) at a 1:1000 dilution. After washing three times
with TBST (1 × TBS (Bio-Rad) containing 0.1% Tween 20), the membrane was
incubated with a secondary antibody for the size marker (Bio-Rad, 161-0380) and
an horseradish peroxidase (HRP)-conjugated goat anti-rabbit or mouse IgG sec-
ondary antibody (Santa Cruz Biotechnology, sc-2004 and sc-2005, respectively) at a
1:000 dilution at room temperature for 1–3 h and washed again. A chemilumi-
nescent reagent (Clarify Western ECL Substrate; Bio-Rad) was subsequently applied
onto the blotted membrane. The luminescence signal was detected using a chilled
charge-coupled device digital imaging camera (LAS4000; Fujiﬁlm). Full blot images
are shown in Supplementary Fig. 17. For H3K27ac and Gapdh, bands were quan-
tiﬁed using Image J. Statistical analyses of the band intensities of H3K27ac per those
of Gapdh were performed by F-test and two-sided Student’s t-test.
Immunocytochemistry. Each of control, Actb-knockout and Srf-overexpressing
NPCs were seeded on a gelatin-coated culture plate. Cells were ﬁxed with 4%
paraformaldehyde (Nacalai Tesque) and permeabilized with 0.5% TritonX-100 in
PBS. These cells were treated with Blocking One (Nacalai Tesque) and reacted with
Rabbit anti-Mkl1 antibody (Abcam, 49311) at a 1:200 dilution overnight. Speci-
mens were subsequently reacted with Alexa Fluor 594-conjugated goat anti-rabbit
IgG (Thermo Fisher Scientiﬁc, A-11012) at a 1:500 dilution and mounted with
VECTASHIELD Mounting Medium (Vector Laboratories) followed by observation
using an inverted IX73 ﬂuorescence microscope (Olympus).
Microarray. Total RNA was extracted using RNeasy Mini Kit and assessed using
RNA 6000 LabChip kit and Agilent 2100 Bioanalyzer (Agilent Technologies).
High-quality RNA was used in the subsequent experiments. Microarray experi-
ments used systems of two manufacturers (Agilent Technologies and Affymetrix)
and were performed as follows. For Agilent Technologies products, 200 ng of total
RNA was reverse-transcribed and ampliﬁed using Low RNA Input Fluorescent
Linear Ampliﬁcation Kit. The resultant cDNA was labeled with Cyanine 3-CTP,
hybridized to SurePrint G3 Mouse GE 8 × 60 K, and washed following the man-
ufacturer’s instructions. The cDNA were scanned with an Agilent Scanner.
Fluorescence intensities of the scanned images were subsequently quantiﬁed using
Feature Extraction software. For Affymetrix products, 200 ng of total RNA was
subjected to cDNA synthesis with GeneChip WT PLUS Reagent Kit and the
resultant cDNA was fragmented and hybridized to Mouse Gene 2.0 ST Array. After
hybridization, GeneChip arrays were washed and stained by GeneChip Fluidics
Station 450 and detected by Scanner 3000 TG system following the manufacturer’s
standard protocols. The array data were analyzed for comparison among samples
using GeneSpring software. Gene expression values were normalized by the
exclusion of low-signal-intensity data and percentile shifts. The tissue expression of
the genes was analyzed using DAVID functional annotation analysis18,19.
Chromatin immunoprecipiation sequencing. ChIP-seq analysis was performed
according to a previous report with minor modiﬁcations11. Around 5.0 × 106 cells
per 10 cm dish were ﬁxed in 1% paraformaldehyde at room temperature for 10 min
followed by quenching with 125 mM glycine at room temperature for 5 min. Fixed
cells were washed with cold PBS twice. Cells were collected by scraper and cen-
trifuged at 700 × g for 3 min and then resuspended in nucleic lysis buffer (10 mM
Tris-HCl, 10 mM EDTA, 1% SDS and 200 mM NaCl pH 7.5). The genomic DNA
was fragmented with Bioruptor (Cosmo Bio) at 4 °C to a size range between 300
and 600 bp. Cell contaminants were removed by centrifugation. A part of the
cleared solution was used as the input sample. An anti-SRF antibody (clone
D71A9; Cell Signaling Technology, 5147) at a 1:20 dilution or anti-Histone H3
acetyl Lys27 antibody (Active Motif, 39133) at a 1:50 dilution were prebound by
incubating with Protein-G Dynabeads (Thermo Fisher Scientiﬁc) in immunopre-
cipitation (IP) dilution buffer (16.7 mM Tris-HCl, 1.2 mM EDTA, 1.1% (vol/vol)
Triton X-100, 167 mM NaCl, and 0.01% SDS pH 8.0) and then incubated at 4 °C
overnight with constant rotation. Samples were washed twice with IP dilution
buffer, twice with low NaCl buffer (20 mM Tris-HCl, 2 mM EDTA, 1% Trion X-
100, 150 mM NaCl and 0.1% SDS pH 8.0), twice with high NaCl buffer (20 mM
Tris-HCl, 2 mM EDTA, 1% Trion X-100, 500 mM NaCl and 0.1% SDS pH 8.0),
twice with LiCl buffer (10 mM Tris-HCl, 1 mM EDTA, 250 mM LiCl, 1% NP-40
and 1% sodium deoxycholate pH 8.0), and twice with TE (10 mM Tris-HCl and 1
mM EDTA pH 8.0). The DNA–protein complex was ﬁnally eluted with elution
buffer (25 mM Tris-HCl, 5 mM EDTA and 0.5% SDS pH 7.5). Eluates and input
samples were treated with Pronase (Roche) at 42 °C for 2 h followed by 65 °C
overnight with constant shaking. DNA was puriﬁed with MinElute Reaction
Cleanup Kit (Qiagen). Immunoprecipitated DNA was ligated with adaptors of
Illumina TruSeq using TruSeq ChIP Sample Prep Kit (Illumina). Libraries were
assessed for quality and quantity using Agilent Bioanalyzer 2000 and KAPA
Library Quantiﬁcation Kit for Illumina (KAPA Biosystems). The libraries were
single-end (50 bp) sequenced on NextSeq 500 or Illumina HiSeq 2500.
ChIP-seq data analysis. All the sequenced reads were surveyed and the low-
quality bases at the 3′-read ends and the adaptors were trimmed using cutadapt-
1.1458. Trimmed reads with < 20 bp were discarded. Untrimmed and trimmed
reads of 20 bp or longer were mapped to mouse genome (mm9) with BWA 0.7.1259
using the default parameters. The reads with high mapping quality (MAPQ >= 20)
were used for further analysis and the duplicate reads were removed with Picard
tools (http://broadinstitute.github.io/picard/). MACS ver. 1.3.7.160 with parameters
(--mfold= 8 --gsize= 2.43e+09 --pvalue 1e-5) was used to identify enriched
regions over input samples. Peaks falling within blacklisted regions (https://sites.
google.com/site/anshulkundaje/projects/blacklists) were excluded from further
analysis. Binding sites were deﬁned as sites detected in two independent experi-
ments. Average proﬁles and heatmaps for ChIP-seq data were generated by
ngsplot-2.4761. The mergePeaks program (HOMER software v4.9.162) was used to
test the statistical signiﬁcance of the overlap. Super-enhancers were identiﬁed by
H3K27ac with ROSE pipelines5,42,44.
Motif analysis. Promoter sequences (from – 1000 to + 200 bp relative to TSS)
were obtained by using data from the RefSeq database (https://www.ncbi.nlm.nih.
gov/refseq/). The nucleotide sequences (from – 25 to + 25 bp or from – 100 to +
100 bp relative to the peak center of the ChIP-seq data) were obtained for
co-enrichment analysis of the TFs. To identify putative binding sites of
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DNA-binding proteins, the sequences were scanned with MATCH programs63
(cut-off=minFP) using vertebrate position weight matrices from the TRANSFAC
Professional database (BioBase)64. For each matrix, the enrichment of the hit
sequences in a set of sequences was compared with that in whole genomic regions
and P-values were calculated by Fisher’s exact test.
Chromatin accessibility assay. Five thousand cells were isolated from each
sample and lysed in 5 to 10 μl of ice-cold ATAC lysis buffer (10 mM Tris-HCl, 10
mM NaCl, 3 mM MgCl2, and 0.1% IGEPAL CA-630 pH 7.5) for 10 min. The
nuclear extraction step was skipped and Illumina’s adaptors were ligated using the
transposase reaction mix of Nextera DNA Sample Prep Kit (Illumina), and the
samples were incubated for 30 min at 37 °C. Indices were incorporated using
Nextera Index Kit (Illumina) in the ampliﬁcation step. The libraries were puriﬁed
using Ampure XP beads (Beckman Coulter) to remove remaining adapters. The
libraries were paired-end sequenced on Illumina HiSeq 2500 for 64 cycles.
Sequenced reads were handled as described in ChIP-seq data analysis above, except
that the reads mapping to the mitochondrial DNA (chrM) were excluded for
further analysis. ATAC-seq peak sites were deﬁned as sites detected in two inde-
pendent experiments.
Hi-C experiments. Cells were ﬁxed with 1% formaldehyde for 10 min at room
temperature. Glycine was added to 125 mM ﬁnal concentration and incubated for
5 min at room temperature. Tubes were placed on ice for 15 min. Cells were
washed in ice-cold PBS and 1–2 × 106 ﬁxed cell pellets were used for the following
steps. Cell pellets were resuspended in 3 C lysis buffer (10 mM Tris-HCl, 10 mM
NaCl, and 0.2% NP-40 pH 8.0) with 1 × protease inhibitor cocktail (Roche) and
incubated on ice for 20 min. After centrifugation, pellets were resuspended in 1.2 ×
NE Buffer 2 (New England Biolabs) with 0.3% SDS and incubated for 1 h at 37 °C
with constant shaking. Triton X-100 was subsequently added to a 2% ﬁnal con-
centration, and samples were incubated for 1 h at 37 °C. Samples were further
incubated overnight at 37 °C with shaking after the addition of HindIII. After
centrifugation, pellets were sequentially incubated in 1 × NE Buffer 2 with 300 U
HindIII for over 8 h at 37 °C with constant shaking in “Fill-in Mix” (1 × NE Buffer
2, 15 µM each of dATP, dGTP, dTTP, and 15 µM Biotin-14-dCTP (Thermo Fisher
Scientiﬁc) with 25 U Klenow (New England Biolabs)) for 45 min at 37 °C and in
“Ligation Mix” (1 × T4 DNA ligase buffer (New England Biolabs) with 60 U/l of T4
DNA ligase (Thermo Fisher Scientiﬁc)) overnight at 16 °C. After Tris-HCl (pH 7.5)
was added at 10 mM, samples were treated with 100 µg/ml RNase A for 30 min at
37 °C, subjected to reverse-crosslinking and proteinase K treatment overnight at 65
°C in the presence of 400 µg/ml proteinase K followed by incubation in 800 µg/ml
proteinase K for an additional 2 h. DNA was extracted by ethanol precipitation
after treatment with phenol/chloroform twice and with chloroform once, and
resolved in 10 mM Tris-HCl (pH 7.5) (Hi-C DNA). Hi-C DNAs were checked for
quantity and quality by Qubit dsDNA HS Assay Kits (Thermo Fisher Scientiﬁc)
and electrophoresis, respectively.
To generate next-generation sequencing libraries, Hi-C DNAs were mixed with
“T4 DNA pol mix” (1 × NE Buffer 2, 1 × BSA, 100 µM dATP, 100 µM dGTP, and
2.5 U of T4 DNA polymerase (New England Biolabs)) and incubated for 2 h at 12 °
C. These DNAs were puriﬁed by ethanol precipitation after treatment with phenol/
chloroform twice and with chloroform once, and resolved in nuclease-free water.
DNAs were next sheared (300–500 bp) using the DNA Shearing System S220
(Covaris) and subjected to size selection using AMPure XP beads (Beckman
Coulter). The size-selected DNAs were subjected to biotin pull-down using
Dynabeads MyOne Streptavidin C1 (Thermo Fisher Scientiﬁc). The sequencing
libraries were prepared using Nextera Mate Pair Sample Prep Kit (Illumina) and
KAPA Real-Time Library Ampliﬁcation Kit (KAPA Biosystems), and puriﬁcation
was done with AMPure XP beads. The libraries were checked for quality using a
Bioanalyzer High Sensitivity DNA chip and subjected to paired-end sequencing
(100-bp read length) using HiSeq 2500.
Hi-C data analysis. Read pairs were individually mapped to the mouse genome
(UCSC mm9) using the Hi-C-pro pipeline65 as the default parameter of bowtie2
options (Global options: “--very-sensitive -L 30 --score-min L,-0.6,-0.2 --end-to-
end”; Local options: “--very-sensitive -L 20 --score-min L,-0.6,-0.2 --end-to-end”).
After read mapping, each side of the mapped reads was applied to the hiclib
pipeline66. First, uniquely mapped paired-reads were assigned to HindIII frag-
ments. Only those with correct orientations were considered valid pairs, and non-
ligated and self-ligated read pairs were ﬁltered out. Fragment-level ﬁlters were next
applied to remove invalid reads: reads that started within 5 bp from the restriction
sites, duplicated read pairs, extremely large and small restriction fragments ( > 100
kbp and < 100 bp, respectively), and extremely high and low count restriction
fragments (top 0.5% of all counts and zero counts, respectively). Biological repli-
cates were merged, and Hi-C contact heatmaps were generated in 200 kb non-
overlapping genomic bins for both merged samples (mainly used for visualization)
and for single biological replicates. To correct the bias of the contact heatmaps,
iterative correction was performed with the following steps: diagonal removal was
applied to only the ﬁrst diagonal (“removeDiagonal(0)”), bin removal was done by
the sequence fraction (0.5), and ﬁnally high trans contacts (the fraction of the top
0.05% trans contacts) were removed. The bias-corrected contact heatmaps were
used to generate the A/B compartment proﬁles in each chromosome as previously
described37 by the hiclib pipeline with a small modiﬁcation in the Δ“doC-
isPCADomains(domaidunction= ”lieverman-”)” function including observed/
expected analysis, covariance matrix generation from the Pearson’s correlation
matrix, and PCA analysis. The ﬁrst eigenvalues were used to identify A/B com-
partments. As positive and negative eigenvalues are arbitrary, correlation with the
GC content was used to assign positive eigenvalues as ‘A compartment’ and
negative eigenvalues as ‘B compartment’.
Genomic regions with signiﬁcant A/B compartment changes in 200 kb bins
were identiﬁed as previously described38. First, one-way analysis of variance
(ANOVA) test (‘oneway.test’ function in R) was performed for each 200 kb
genomic bin among control (NPCs), Actb knockout (Actb KO), and Srf
overexpression (Srf OE) sample sets to identify genomic regions that exhibit
statistically signiﬁcant variability in A/B compartments (P < 0.05). Second, genomic
regions with either A-to-B or B-to-A compartment changes were selected by
comparing the NPCs with Actb KO or Srf OE in both biological replicates. The
Refseq gene positions (UCSC mm9) were assigned to each 200 kb genomic bin.
For Hi-C data analysis of compartment changes during the reprogramming to
iPSCs, the same analysis as above was performed, and A/B compartment proﬁles
were generated by comparing our NPC data to NSC-derived iPSC data39,
NSC_iPS_p3 (GEO accession numbers: GSM2026282, GSM2026283,
GSM2026284) and NSC_iPS_p20 (GSM2026279, GSM2026280, and
GSM2026281). Speciﬁcally, the summary mapped txt ﬁles (GSE76481)39 were
loaded to the hiclib pipeline using our home-made python script. For the NSC-
derived iPSCs data sets, DpnII was used as the restriction sites. In ANOVA tests,
the two parental NPCs, NSC_iPS_p3, and NSC_iPS_p20 data sets were used. For
the creation of ﬁgures, the merged data sets were used for visualization.
To estimate the association of compartment changes with cell-type-speciﬁc
genes, the number of genes was counted after excluding redundant genes, genes
that were not found in the microarray data and genes annotated with no gene
symbol.
RNA sequencing. RNA sequencing (RNA-seq) was performed to analyze gene
expressions in cells on matrices of different stiffness. One hundred nanograms of
total RNA isolated using RNeasy Mini Kit was used and the libraries were con-
structed using TruSeq Stranded mRNA LT Sample Prep Kit (Illumina). Libraries
were assessed for quality and quantity using Agilent Bioanalyzer 2100 and Qubit
dsDNA HS Assay Kit (Thermo Fisher Scientiﬁc). The libraries were single-end
sequenced on Illumina NextSeq 500. The sequenced reads were mapped to the
mouse reference genome (mm10) using tophat-2.1.067 with the GENCODE version
M14 annotation gtf ﬁle and the aligner Bowtie2-2.2.868 after trimming adaptor
sequences and low-quality bases by cutadapt-1.9.158. The reads with high mapping
quality (MAPQ ≥ 20) were used for further analyses. The expression level of each
gene was calculated as reads per kilobase per million mapped reads (RPKM) by
cufﬂinks-2.2.169 and analyzed using GeneSpring software. Genes whose RPKM was
> 2 in all samples were included. Genes expressed in control NPCs on the 0.5-kPa
matrix more than 2-fold compared with ESCs (GSM1891554 and GSM1847711)
were deﬁned as cell-type-speciﬁc genes on the 0.5 kPa matrix (these genes are not
the same as the cell-type-speciﬁc genes on normal culture dishes that were used for
the experiments, except for experiments that examined the stiffness effects on cell
identity, because the gene expression programs were different). The threshold was
1.1-fold for the selection of downregulated and upregulated genes.
ESC targeting and generation of chimeric mice. To generate Srf-inducible mice,
the Dox-inducible system was employed (Fig. 6c). The Srf-ires-mCherry-pA
sequence was inserted into pBS3141, which was electroporated into KH2 ESCs
(mixed background of 129 and BL/6 strains, from Konrad Hochedlinger) harboring
a Rosa26-promoter-driven M2rtTA allele as described previously41. Established
KH2-Srf ESCs (Rosa-M2rtTA/Col1a1::tetO-Srf-ires-mCherry) were injected into
ICR mouse blastocysts to obtain chimeric mice, in which Srf can be induced in vivo
by adding Dox in drinking water. Four-week-old animals with similar chimerism
were used for the analyses. From them, randomly (without blinding) selected mice
were treated with Dox at 2 µg/ml for 4 or 7 days before subjected to observations
for Srf overexpression (mCherry expression) and phenotypic diagnosis. All
experimental groups contained both females and males.
To determine the differentiation capability of shActb-iPSCs in vivo, cells were
ﬁrst labeled with EGFP by introducing a Tol2 transposon vector carrying CAG-
egfp-ires-pac (puromycin resistance gene) by co-transfection with pCAGGS-
mT2TP11,70 using Lipofectamine 2000. EGFP-labeled shActb-iPSCs were injected
into blastocysts to obtain E14.5 chimeric embryos. The chimeric contribution of
shActb-ESCs was analyzed by immunohistochemistry using an anti-GFP antibody
(see below) (clone 4B10; Cell Signaling Technology).
All experiments using animals were conducted under the ethical guidelines of
Kyoto University.
Histological analysis and immunohistochemistry. All tissue samples were ﬁxed
in 4% paraformaldehyde overnight and embedded in parafﬁn. Sections (5 μm) were
stained with hematoxylin and eosin using standard protocol, and serial sections
were used for immunohistochemical staining. The primary antibodies, which were
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incubated at room temperature for 1–2 h in blocking buffer (2% BSA in PBS), were
rat anti-Red Fluorescent Proteins (clone 5F8, dilution 1:100, Chromotek, 5F8) or
mouse anti-GFP (clone 4B10, dilution 1:100, Cell Signaling Technology, 2955). The
sections were subsequently incubated with HRP-conjugated secondary antibodies
(Histoﬁne Simple Stain; Nichirei Bioscience) at room temperature for 30 min,
followed by chromogen development using DAB (Nichirei Bioscience). The stained
sections were counterstained with Meyer hematoxylin. Specimens were observed
with a reverse BX51 microscope (Olympus).
Data availability. Microarray, ChIP-seq, ATAC-seq, RNA-seq, and Hi-C data
have been deposited in NCBI Gene Expression Omnibus under GSE90034. Other
data that support the ﬁndings of this study are available from the corresponding
authors upon reasonable request.
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